393 related articles for article (PubMed ID: 32398315)
21. The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.
Christensen ND; Chen KM; Hu J; Stairs DB; Sun YW; Aliaga C; Balogh KK; Atkins H; Shearer D; Li J; Brendle SA; Gowda K; Amin S; Walter V; Viscidi R; El-Bayoumy K
Chem Biol Interact; 2021 Jan; 333():109321. PubMed ID: 33186600
[TBL] [Abstract][Full Text] [Related]
22. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
23. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of human papillomavirus-related head and neck cancer.
Joseph AW; D'Souza G
Otolaryngol Clin North Am; 2012 Aug; 45(4):739-64. PubMed ID: 22793850
[TBL] [Abstract][Full Text] [Related]
26. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
27. [Role of human papillomavirus in head and neck squamous cell carcinomas].
Guangxue C; Xiaolei G; Xinhua L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Apr; 35(2):187-191. PubMed ID: 28682551
[TBL] [Abstract][Full Text] [Related]
28. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
29. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus, smoking, and head and neck cancer.
Sinha P; Logan HL; Mendenhall WM
Am J Otolaryngol; 2012; 33(1):130-6. PubMed ID: 21546122
[TBL] [Abstract][Full Text] [Related]
31. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue.
Cladel NM; Budgeon LR; Balogh KK; Cooper TK; Hu J; Christensen ND
Virology; 2016 Jan; 488():73-80. PubMed ID: 26609937
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice.
Jabbar S; Strati K; Shin MK; Pitot HC; Lambert PF
Virology; 2010 Nov; 407(1):60-7. PubMed ID: 20797753
[TBL] [Abstract][Full Text] [Related]
33. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
35. Barriers to generating PDX models of HPV-related head and neck cancer.
Facompre ND; Sahu V; Montone KT; Harmeyer KM; Nakagawa H; Rustgi AK; Weinstein GS; Gimotty PA; Basu D
Laryngoscope; 2017 Dec; 127(12):2777-2783. PubMed ID: 28561270
[TBL] [Abstract][Full Text] [Related]
36. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
[TBL] [Abstract][Full Text] [Related]
37. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.
Paz IB; Cook N; Odom-Maryon T; Xie Y; Wilczynski SP
Cancer; 1997 Feb; 79(3):595-604. PubMed ID: 9028373
[TBL] [Abstract][Full Text] [Related]
39. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]